Kirsi Penttinen Email

Senior Scientist . StemSight - Vision Unlimited

Current Roles

Employees:
20
Revenue:
$3.1M
About
StemSight develops off-the-shelf regenerative cell therapies for corneal blindness. Our expertise is in the combination of iPS-derived cells with functional biomaterials - for FASTER tissue regeneration, SAFER cell therapies and EASIER cell delivery.
StemSight - Vision Unlimited Address

Tampere, null
FI
StemSight - Vision Unlimited Email